Your browser doesn't support javascript.
loading
Combined 177 Lu-PSMA-617 PRLT and abiraterone acetate versus 177 Lu-PSMA-617 PRLT monotherapy in metastatic castration-resistant prostate cancer: An observational study comparing the response and durability.
Suman, Sonam; Parghane, Rahul V; Joshi, Amit; Prabhash, Kumar; Talole, Sanjay; Basu, Sandip.
  • Suman S; Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Centre Annexe, Mumbai, India.
  • Parghane RV; Homi Bhabha National Institute, Mumbai, India.
  • Joshi A; Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Centre Annexe, Mumbai, India.
  • Prabhash K; Homi Bhabha National Institute, Mumbai, India.
  • Talole S; Homi Bhabha National Institute, Mumbai, India.
  • Basu S; Department of Medical Oncology, Tata Memorial Centre, Mumbai, India.
Prostate ; 81(15): 1225-1234, 2021 11.
Article en En | MEDLINE | ID: mdl-34469602
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antígeno Prostático Específico / Radiofármacos / Neoplasias de la Próstata Resistentes a la Castración / Acetato de Abiraterona / Lutecio / Antineoplásicos Tipo de estudio: Observational_studies Límite: Adult / Aged / Aged80 / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antígeno Prostático Específico / Radiofármacos / Neoplasias de la Próstata Resistentes a la Castración / Acetato de Abiraterona / Lutecio / Antineoplásicos Tipo de estudio: Observational_studies Límite: Adult / Aged / Aged80 / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article